An Optimized Background Regimen Design to Evaluate the Contribution of Levofloxacin to Multidrug-Resistant Tuberculosis Treatment Regimens: Study Protocol for a Randomized Controlled Trial
Trials - United Kingdom
doi 10.1186/s13063-017-2292-x
Full Text
Open PDFAbstract
Available in full text
Date
November 25, 2017
Authors
Publisher
Springer Science and Business Media LLC